/Investor DB

Oost NL — 2023 Investments

4 investments dated 2023 · listed companies and verified rows first · show all

Deltadeltadevteam.comin𝕏May 2023

Delta Development Team manufactures temperature-controlled medical transport and storage devices, including smart blood coolers and autonomous refrigeration units, for healthcare facilities and blood banks.

HardwareHealthtechLogistics & Supply ChainMedical Devices

Co-investorsAggie Angel NetworkAZ Venture Capital Inc.Central Texas Angel NetworkSymbiotic Venturesi&i Biotech Fund

Delta Life Sciencedeltalifescience.comMay 2023

Delta Life Science develops the inQuiQ, a label-free biosensing instrument that uses integrated photonics to measure biomolecular binding affinity and kinetics (KD, ka, kd) in real time from small sample volumes.

BiotechDeep TechHardware

Co-investorsi&i Biotech Fund

Oost NLoostnl.cominApr 2023

Oost NL is a government-commissioned economic development organization serving the Dutch provinces of Gelderland and Overijssel.

Enterprise SoftwareGovTechArnhem, NL

Wendy de Jong(CEO)inFons de Zeeuw(Director International)inFreek Welling(Director Capital)inLiane van der Veen(Director Business Development)inWieteke Numan(Director Finance, Risk & Operations)in

Co-investorsEvercuriousVCInnovation IndustriesInvest-NLSHIFT

Tagworks Pharmaceuticalstagworkspharma.comin𝕏Jun 2023

Tagworks Pharmaceuticals develops cancer therapies using its Click-to-Release platform, a chemical reaction that activates antibody-drug conjugates (ADCs), masked immunomodulators, and other prodrugs on-target while deactivating radioimmunotherapies off-target.

BiotechHealthtechMedical DevicesNijmegen, NL

Co-investorsBifLightstone VenturesNew Enterprise Associates (NEA)Novartis Venture FundYsios CapitalClarus Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.